• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Anticoagulation for atrial fibrillation.心房颤动的抗凝治疗
Can Fam Physician. 2005 Dec;51(12):1629.
2
Between the Devil and the Deep Blue Sea--balancing the risks and potential benefits of warfarin for older people with atrial fibrillation.进退两难——权衡华法林对老年房颤患者的风险与潜在益处。
Age Ageing. 2004 Nov;33(6):544-7. doi: 10.1093/ageing/afh211.
3
Anticoagulation in the octogenarian with atrial fibrillation.八十岁房颤患者的抗凝治疗
Med Health R I. 2009 Apr;92(4):152-4.
4
Pro: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'. Why warfarin should really be the drug of choice for stroke prevention in elderly patients with atrial fibrillation.正方观点：“华法林应该是老年房颤患者血栓预防的首选药物”。为什么华法林确实应该成为老年房颤患者预防中风的首选药物。
Thromb Haemost. 2008 Jul;100(1):14-5. doi: 10.1160/TH08-06-0344.
5
Contra: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'. Caveats regarding use of oral anticoagulant therapy among elderly patients with atrial fibrillation.反对观点：“华法林应是老年房颤患者血栓预防的首选药物”。关于老年房颤患者使用口服抗凝治疗的注意事项。
Thromb Haemost. 2008 Jul;100(1):16-7. doi: 10.1160/TH08-06-0343.
6
[Warfarin treatment in atrial fibrillation].[心房颤动的华法林治疗]
Tidsskr Nor Laegeforen. 2006 Sep 21;126(18):2409; author reply 2409-10.
7
The CHADS2 score for stroke risk stratification in atrial fibrillation--friend or foe?用于心房颤动中风风险分层的CHADS2评分——是友还是敌？
Thromb Haemost. 2010 Jul;104(1):45-8. doi: 10.1160/TH09-11-0757. Epub 2010 May 10.
8
Use of anticoagulation in elderly patients with atrial fibrillation who are at risk for falls.在有跌倒风险的老年房颤患者中使用抗凝治疗。
Ann Pharmacother. 2008 Apr;42(4):523-32. doi: 10.1345/aph.1K498. Epub 2008 Mar 11.
9
[Time to revise guidelines concerning anticoagulants in atrial fibrillation].[是时候修订有关心房颤动抗凝治疗的指南了]
Lakartidningen. 2002 Oct 31;99(44):4375-7.
10
Cost-effectiveness of genotype-guided warfarin therapy for anticoagulation in elderly patients with atrial fibrillation.基因分型指导的华法林治疗在老年房颤患者抗凝治疗中的成本效益
Am J Geriatr Pharmacother. 2009 Aug;7(4):197-203. doi: 10.1016/j.amjopharm.2009.07.002.

本文引用的文献

1
A risk score for predicting stroke or death in individuals with new-onset atrial fibrillation in the community: the Framingham Heart Study.社区中新发房颤患者发生卒中或死亡的风险评分：弗雷明汉心脏研究
JAMA. 2003 Aug 27;290(8):1049-56. doi: 10.1001/jama.290.8.1049.
2
A comparison of rate control and rhythm control in patients with atrial fibrillation.心房颤动患者心率控制与节律控制的比较。
N Engl J Med. 2002 Dec 5;347(23):1825-33. doi: 10.1056/NEJMoa021328.
3
ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary. A Report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation): developed in Collaboration With the North American Society of Pacing and Electrophysiology.美国心脏病学会/美国心脏协会/欧洲心脏病学会心房颤动患者管理指南：执行摘要。美国心脏病学会/美国心脏协会实践指南工作组和欧洲心脏病学会实践指南与政策会议委员会（心房颤动患者管理指南制定委员会）报告：与北美心脏起搏和电生理学会合作制定。
J Am Coll Cardiol. 2001 Oct;38(4):1231-66. doi: 10.1016/s0735-1097(01)01587-x.
4
Primary prevention of ischemic stroke: A statement for healthcare professionals from the Stroke Council of the American Heart Association.缺血性卒中的一级预防：美国心脏协会卒中委员会给医疗专业人员的声明
Stroke. 2001 Jan;32(1):280-99. doi: 10.1161/01.str.32.1.280.
5
Antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks.非瓣膜性心房颤动且无既往卒中或短暂性脑缺血发作史患者预防卒中的抗血小板治疗
Cochrane Database Syst Rev. 2000(2):CD001925. doi: 10.1002/14651858.CD001925.
6
Implementing evidence based medicine in general practice: audit and qualitative study of antithrombotic treatment for atrial fibrillation.在全科医疗中实施循证医学：心房颤动抗栓治疗的审计与定性研究
BMJ. 1999 May 15;318(7194):1324-7. doi: 10.1136/bmj.318.7194.1324.
7
The risk for and severity of bleeding complications in elderly patients treated with warfarin. The National Consortium of Anticoagulation Clinics.老年患者接受华法林治疗时出血并发症的风险及严重程度。全国抗凝诊所联盟。
Ann Intern Med. 1996 Jun 1;124(11):970-9. doi: 10.7326/0003-4819-124-11-199606010-00004.

Anticoagulation for atrial fibrillation.

作者信息

Greiver Michelle

出版信息

Can Fam Physician. 2005 Dec;51(12):1629.

PMID:16805080
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1479495/
Abstract
摘要